A bug taxonomist turned four kitchen-table lipsticks into a $150 million makeup company - by insisting cosmetics do the work of skincare.
Before Sheena Zadeh sorted lipstick shades, she sorted insects. A UC Irvine biology graduate, she spent time as a taxonomist - the painstaking work of classifying specimens by tiny, exact differences. It is a strange line on the resume of a beauty founder, and also a tell. Kosas, the Los Angeles company she started in 2015, is built on the idea that the small details of a formula are the whole product. The pigment is almost incidental. The question the brand keeps asking is quieter: what is this doing for your skin?
That question turned four lipsticks, mixed at a kitchen table and sold from a website, into a company Forbes estimates does about $150 million in annual sales. Kosas now lists roughly 200 products, sells in about 33 countries, and sits on the shelves at Sephora and some 220 other retailers. It got there without the cash-torching launch that defines much of modern beauty - and that restraint is arguably the most interesting thing about it.
Kosas describes itself in four words - "100% Makeup. 100% Skincare." - and, more plainly, as "makeup for skincare freaks." The positioning is not decoration. Every product is meant to be a skincare formula that happens to carry color. The concealer has caffeine, peptides and hyaluronic acid. The lip oil plumps with actives rather than menthol tingle. The blush is talc-free and cut with squalane. The pitch is not "clean, so you should feel good about it." The pitch is "it performs, and it is also good for your skin." That ordering - performance first, virtue second - is why Kosas outgrew clean beauty's early reputation as a compromise.
Zadeh's stated purpose is disarmingly small: "I exist to make beautiful things." There is no ten-point manifesto. In an industry that markets ingredients as ideology, Kosas treats "clean" - free of things like parabens and sulfates - as a baseline requirement, not the headline. The headline is whether you want to put it on again tomorrow.
The founding story is unusually literal. Zadeh mixed the first four lip shades while taking a portrait-painting class - earthy neutrals and pinks meant to enhance a natural lip rather than replace it. She bootstrapped the company with roughly $70,000 of her own money, launched from her kitchen table, and sold only on the website for the first full year. Revenue in that stretch was, by her own account, a few thousand dollars a month. It was not a rocket. It was a proof.
The business stayed small until 2017, when the line expanded into blush and highlighter. In 2018 it landed in Goop's stores, the kind of tastemaker placement that signals a brand is real before the masses have heard of it. Then, in 2019, Sephora began carrying Kosas nationally, and the curve bent. What is easy to miss is the sequence: Kosas proved demand online, earned tastemaker credibility, and only then let mass prestige retail scale it. The brand did not skip steps.
If one product explains Kosas, it is the Revealer Concealer. It reads like an eye cream - caffeine to brighten, arnica and panthenol to soothe, hyaluronic acid and peptides to hydrate - and wears like medium-coverage makeup. It became a viral bestseller, the kind of product that sells out and gets featured by the likes of Hailey Bieber and Kim Kardashian. Around it sits a coherent shelf: the Wet Lip Oil, a vegan gloss that plumps with hyaluronic acid and peptides; Cloud Blush, a dual-tone talc-free formula; DreamBeam, a facial sunscreen built to wear under makeup; and the tinted face oils that started the complexion story.
Here is the number that should make the industry uncomfortable: Kosas has raised roughly $19 million in total, against an estimated $150 million in yearly sales. The first institutional money - a Series A of about $3 million from CircleUp Growth Partners - did not go to a paid-media blitz. It went to building an in-house formulation lab. When your moat is the formula, you fund the formula. In April 2022 the company added a $12 million Series B led by Stripes, with participation from Erewhon, Califia Farms and existing backers.
The business model is a two-lane road: full-margin direct-to-consumer e-commerce on Shopify, and prestige wholesale through Sephora, Nordstrom, Credo, The Detox Market, Revolve, Neiman Marcus, Net-a-Porter, Cult Beauty and Mecca. About 30% of sales now come from outside the United States. And unlike the many launch-and-burn brands it shares a category with, Kosas has reported multiple years of profitability. In a market built on subsidized growth, making money is the actual disruption.
Kosas sits in the skincare-makeup hybrid lane of prestige beauty, alongside clean-leaning peers like Ilia, Saie, Tower 28 and Merit, and within arm's reach of the big prestige players - Rare Beauty, Charlotte Tilbury, NARS - that now sell their own "skin-first" complexion products. That crowding is a kind of validation. The line between makeup and skincare that Kosas bet on a decade ago has mostly dissolved, and the incumbents are chasing the category it helped define. Its customers skew skincare-conscious millennials and Gen Z who read ingredient lists and expect their concealer to earn its place in a routine, not just cover it.
At ten years old, Kosas has the profile of a brand at a fork: profitable, global, capital-efficient, and - per reporting around its anniversary - the subject of acquisition interest. Whether it stays independent or sells, the underlying bet has already paid off. The company took a niche idea, treated "clean" as a floor rather than a ceiling, and let the product do the arguing.
The person Kosas is built for is not chasing a full-glam transformation. She is more likely reading the back of the box than the front. The brand's audience skews toward skincare-literate millennials and Gen Z shoppers who already spend on serums and sunscreen and want their color products to slot into that routine rather than fight it. For that customer, a concealer that contains peptides is not a gimmick - it is a reason to consolidate two purchases into one. The "makeup for skincare freaks" line works because it names a real person rather than an aspiration, and the roughly 30% of revenue coming from overseas suggests the type exists well beyond California. Clean beauty was often framed as a coastal-US preoccupation. Kosas is quiet evidence that "makeup that is good for your skin" translates in most languages.
The problems it solves are equally unglamorous and equally durable. Traditional makeup often sits on top of skin and, over a long day, works against it - drying, settling, emphasizing the texture it was meant to smooth. Skincare and cosmetics have historically been separate steps, separate budgets and separate shelves. Kosas collapses that gap: the value proposition is that you can reapply throughout the day without feeling like you are punishing your face, and that "clean" no longer has to mean "underperforms." Solving the second problem is what let the brand escape the early clean-beauty trap, where virtue was the entire pitch and the product was the afterthought.
What holds all of this together is the lab. Kosas is founder-led and unmistakably product-first, with formulation kept in-house rather than outsourced to a contract manufacturer's catalog. That is why the first real capital went to building the lab instead of buying reach - control over the formula is the difference between a brand that markets a trend and one that can actually ship the next version of it. Zadeh frames the daily act of putting on makeup as a small ceremony of self-care rather than a chore or a mask, and that framing shows up in the products: comfortable finishes, active ingredients, shades built to flatter rather than costume. It is a coherent worldview compressed into a tube, and coherence is rarer in beauty than it sounds.